Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for COLL

Stock Name	Collegium Pharmaceutical Inc
Ticker	COLL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US19459J1043
LEI	54930049FXZMTLW8D496

Show aggregate COLL holdings

News associated with COLL

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at HC Wainwright: HC Wainwright upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) to a strong-buy rating in a report released on Monday morning, MarketBeat Ratings reports. The firm currently has $44.00 target price on the specialty pharmaceutical company’s stock. COLL has been the subject of several other reports. Wall Street Zen upgraded Collegium Pharmaceutical from a […] - 2025-08-14 03:00:52
Collegium Pharmaceutical (NASDAQ:COLL) Stock Rating Upgraded by Wall Street Zen: Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Saturday. Separately, Piper Sandler reissued a “neutral” rating and set a $37.00 price objective (up previously from $36.00) on shares of Collegium Pharmaceutical […] - 2025-08-11 04:33:01
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH: Universal Beteiligungs und Servicegesellschaft mbH lifted its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 124,671 shares of the specialty pharmaceutical company’s stock after purchasing an additional 2,895 […] - 2025-07-29 05:22:58
Victory Capital Management Inc. Sells 60,823 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Victory Capital Management Inc. cut its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 10.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 498,713 shares of the specialty pharmaceutical company’s stock after selling 60,823 shares during the quarter. Victory Capital […] - 2025-07-24 04:53:18
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Bank of New York Mellon Corp: Bank of New York Mellon Corp decreased its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.1% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 242,261 shares of the specialty pharmaceutical company’s stock after selling 10,426 shares during the period. Bank of New York Mellon Corp’s holdings in Collegium Pharmaceutical were […] - 2025-07-23 04:42:46
Collegium Pharmaceutical (NASDAQ:COLL) to Repurchase $150.00 million in Outstanding Stock: Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) announced that its Board of Directors has approved a stock repurchase program on Monday, July 7th, RTT News reports. The company plans to buyback $150.00 million in outstanding shares. This buyback authorization allows the specialty pharmaceutical company to repurchase up to 15.4% of its shares through open market […] - 2025-07-09 02:16:45
Collegium Pharmaceutical Breaks Above 200-Day Moving Average - Bullish for COLL: In trading on Monday, shares of Collegium Pharmaceutical Inc (Symbol: COLL) crossed above their 200 day moving average of $31.15, changing hands as high as $31.83 per share. Collegium Pharmaceutical Inc shares are currently trading up about 4.2% on the day. The chart below sho - 2025-07-07 12:54:17
Principal Financial Group Inc. Sells 71,695 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Principal Financial Group Inc. decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,573,356 shares of the specialty pharmaceutical company’s stock after selling 71,695 shares during the quarter. Principal […] - 2025-07-07 05:54:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Illinois Municipal Retirement Fund: Illinois Municipal Retirement Fund lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 8.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,820 shares of the specialty pharmaceutical company’s stock after selling 1,384 shares during the quarter. Illinois Municipal Retirement Fund’s […] - 2025-07-04 05:19:14
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Ritholtz Wealth Management: Ritholtz Wealth Management lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 5.0% during the 1st quarter, Holdings Channel.com reports. The firm owned 32,108 shares of the specialty pharmaceutical company’s stock after selling 1,676 shares during the quarter. Ritholtz Wealth Management’s holdings in Collegium Pharmaceutical were worth $958,000 as of its most […] - 2025-06-18 05:56:50
Exchange Traded Concepts LLC Decreases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Exchange Traded Concepts LLC cut its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 16.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 62,426 shares of the specialty pharmaceutical company’s stock after selling 12,669 shares during […] - 2025-06-18 05:18:59
Farther Finance Advisors LLC Raises Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Farther Finance Advisors LLC boosted its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.5% in the first quarter, Holdings Channel.com reports. The institutional investor owned 11,091 shares of the specialty pharmaceutical company’s stock after acquiring an additional 477 shares during the period. Farther Finance Advisors LLC’s holdings in Collegium Pharmaceutical were worth […] - 2025-06-18 04:30:54
California State Teachers Retirement System Has $862,000 Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): California State Teachers Retirement System reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 30,093 shares of the specialty pharmaceutical company’s stock after selling 856 shares during the period. California State Teachers Retirement System’s holdings in Collegium Pharmaceutical were […] - 2025-06-11 05:04:51
Wellington Management Group LLP Lowers Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Wellington Management Group LLP reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 22.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 88,591 shares of the specialty pharmaceutical company’s stock after selling 26,049 shares during the period. Wellington Management Group […] - 2025-06-06 05:04:54
Bank of America Corp DE Trims Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Bank of America Corp DE decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 29.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 86,096 shares of the specialty pharmaceutical company’s stock after selling 36,093 shares during the period. Bank of America Corp DE’s holdings in Collegium Pharmaceutical were worth […] - 2025-06-02 04:38:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by ProShare Advisors LLC: ProShare Advisors LLC boosted its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 28.8% in the 4th quarter, Holdings Channel reports. The fund owned 11,196 shares of the specialty pharmaceutical company’s stock after acquiring an additional 2,506 shares during the quarter. ProShare Advisors LLC’s holdings in Collegium Pharmaceutical were worth $321,000 […] - 2025-05-30 05:06:52
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $43.80 Average Price Target from Brokerages: Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five ratings firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price […] - 2025-05-21 03:14:51
Voya Investment Management LLC Cuts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Voya Investment Management LLC lessened its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 7.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,923 shares of the specialty pharmaceutical company’s stock after selling 789 shares during the period. Voya […] - 2025-05-13 04:32:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stake Reduced by Hsbc Holdings PLC: Hsbc Holdings PLC decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 3.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 16,879 shares of the specialty pharmaceutical company’s stock after selling 576 shares during the period. Hsbc Holdings PLC’s holdings in Collegium Pharmaceutical were worth $483,000 at the end […] - 2025-05-07 05:00:51
Barclays PLC Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Barclays PLC increased its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 6.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,754 shares of the specialty pharmaceutical company’s stock after purchasing an additional 4,702 shares during the […] - 2025-05-01 05:14:59
Raymond James Financial Inc. Buys New Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Raymond James Financial Inc. bought a new stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 84,883 shares of the specialty pharmaceutical company’s stock, valued at approximately $2,432,000. Other hedge funds and […] - 2025-04-30 05:10:55
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Legal & General Group Plc: Legal & General Group Plc lessened its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 1.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 91,309 shares of the specialty pharmaceutical company’s stock after selling 1,084 shares during the period. Legal & General Group Plc’s holdings in Collegium Pharmaceutical were […] - 2025-04-24 06:31:01
Russell Investments Group Ltd. Decreases Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Russell Investments Group Ltd. reduced its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 31.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,649 shares of the specialty pharmaceutical company’s stock after selling 6,223 shares […] - 2025-04-24 04:48:48
JPMorgan Chase & Co. Cuts Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): JPMorgan Chase & Co. lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 70.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 82,691 shares of the specialty pharmaceutical company’s stock after selling 194,513 shares during the […] - 2025-04-24 04:16:59
Collegium Pharmaceutical (NASDAQ:COLL) Rating Lowered to Buy at StockNews.com: Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday. A number of other analysts also recently weighed in on the stock. Needham & Company LLC reissued a “buy” rating and set a […] - 2025-04-21 02:22:45
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by Invesco Ltd.: Invesco Ltd. grew its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 19.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,775,760 shares of the specialty pharmaceutical company’s stock after acquiring an additional 289,335 shares during the quarter. Invesco Ltd. owned about […] - 2025-04-16 04:47:00
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at StockNews.com: StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a research report report published on Friday morning. A number of other equities research analysts also recently weighed in on COLL. Needham & Company LLC reaffirmed a “buy” rating and issued a $46.00 target price on […] - 2025-04-14 02:58:57
Vanguard Group Inc. Sells 63,876 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Vanguard Group Inc. cut its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,282,666 shares of the specialty pharmaceutical company’s stock after selling 63,876 shares during the period. Vanguard Group Inc. […] - 2025-04-11 06:16:58
Corebridge Financial Inc. Sells 1,595 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Corebridge Financial Inc. lowered its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 8.5% during the 4th quarter, HoldingsChannel reports. The fund owned 17,084 shares of the specialty pharmaceutical company’s stock after selling 1,595 shares during the period. Corebridge Financial Inc.’s holdings in Collegium Pharmaceutical were worth $489,000 as of its […] - 2025-04-09 04:38:48
American Century Companies Inc. Has $2.45 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): American Century Companies Inc. trimmed its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 18.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 85,466 shares of the specialty pharmaceutical company’s stock after selling 19,447 […] - 2025-04-08 05:04:48

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc COLL holdings

Date	Number of COLL Shares Held	Base Market Value of COLL Shares	Local Market Value of COLL Shares	Change in COLL Shares Held	Change in COLL Base Value	Current Price per COLL Share Held	Previous Price per COLL Share Held
2025-09-26 (Friday)	4,311	USD 148,342	USD 148,342
2025-09-25 (Thursday)	4,311	USD 149,376	USD 149,376	0	USD -2,199	USD 34.65	USD 35.1601
2025-09-24 (Wednesday)	4,311	USD 151,575	USD 151,575
2025-09-17 (Wednesday)	4,283	USD 152,218	USD 152,218	0	USD -342	USD 35.54	USD 35.6199
2025-09-16 (Tuesday)	4,283	USD 152,560	USD 152,560
2025-09-12 (Friday)	4,255	USD 158,797	USD 158,797
2025-09-11 (Thursday)	4,255	USD 166,200	USD 166,200

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of COLL by Blackrock for IE00B3VWM098

Show aggregate share trades of COLL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-08-21 SELL -14 39.520* 30.12 Profit of 422 on sale
2025-07-31 BUY 42 29.860* 30.08
2025-06-30 SELL -28 29.570* 29.91 Profit of 838 on sale
2025-06-25 SELL -14 29.790* 29.91 Profit of 419 on sale
2025-06-20 SELL -28 29.830* 29.91 Profit of 838 on sale
2025-05-23 BUY 14 28.860* 29.98
2025-05-19 SELL -14 29.830* 30.00 Profit of 420 on sale
2025-05-15 SELL -42 29.340* 30.00 Profit of 1,260 on sale
2025-05-12 SELL -14 29.560* 30.02 Profit of 420 on sale
2025-05-09 SELL -14 28.890* 30.03 Profit of 420 on sale
2025-04-30 SELL -14 26.995* 30.22 Profit of 423 on sale
2025-04-24 SELL -28 26.780* 30.35 Profit of 850 on sale
2025-04-17 SELL -14 27.010* 30.54 Profit of 428 on sale
2025-04-15 SELL -42 27.120* 30.61 Profit of 1,286 on sale
2025-04-14 SELL -42 26.730* 30.65 Profit of 1,288 on sale
2025-04-09 SELL -56 26.370* 30.82 Profit of 1,726 on sale
2025-04-07 SELL -98 27.380* 30.92 Profit of 3,031 on sale
2025-04-04 SELL -140 28.140* 30.96 Profit of 4,334 on sale
2025-03-31 BUY 14 29.850* 31.00
2025-03-19 SELL -28 29.850* 31.11 Profit of 871 on sale
2025-03-14 SELL -84 29.460* 31.17 Profit of 2,619 on sale
2025-03-13 SELL -28 29.100* 31.20 Profit of 874 on sale
2025-03-12 SELL -476 29.630* 31.23 Profit of 14,864 on sale
2025-03-07 SELL -28 28.910* 31.30 Profit of 877 on sale
2025-03-06 SELL -42 29.800* 31.33 Profit of 1,316 on sale
2025-03-03 SELL -14 28.440* 31.47 Profit of 441 on sale
2025-02-28 SELL -84 29.050* 31.51 Profit of 2,647 on sale
2025-02-26 SELL -14 28.350* 31.62 Profit of 443 on sale
2025-02-25 SELL -42 28.820* 31.67 Profit of 1,330 on sale
2025-02-18 BUY 70 29.710* 31.87
2025-02-13 BUY 14 30.980* 31.97
2025-02-12 BUY 14 30.530* 32.00
2025-02-11 BUY 42 31.580* 32.01
2025-02-06 BUY 126 30.950* 32.10
2025-01-27 BUY 14 33.910* 32.10
2024-12-30 BUY 70 28.610* 32.30
2024-12-06 BUY 56 29.970* 32.51
2024-12-05 BUY 14 29.870* 32.60
2024-12-04 BUY 70 31.120* 32.65
2024-11-29 BUY 70 30.500* 32.87
2024-11-27 BUY 56 30.710* 33.06
2024-11-26 BUY 14 31.190* 33.15
2024-11-21 BUY 70 30.410* 33.58
2024-11-20 BUY 42 30.000* 33.78
2024-11-18 BUY 168 29.220* 34.32
2024-11-12 BUY 112 31.410* 34.51
2024-11-08 BUY 70 32.160* 34.68
2024-11-07 BUY 210 34.710* 34.68
2024-11-06 BUY 28 34.500* 34.69
2024-10-31 BUY 14 34.140* 35.32
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-08-21	SELL	-14	39.520*	30.12 Profit of 422 on sale
2025-07-31	BUY	42	29.860*	30.08
2025-06-30	SELL	-28	29.570*	29.91 Profit of 838 on sale
2025-06-25	SELL	-14	29.790*	29.91 Profit of 419 on sale
2025-06-20	SELL	-28	29.830*	29.91 Profit of 838 on sale
2025-05-23	BUY	14	28.860*	29.98
2025-05-19	SELL	-14	29.830*	30.00 Profit of 420 on sale
2025-05-15	SELL	-42	29.340*	30.00 Profit of 1,260 on sale
2025-05-12	SELL	-14	29.560*	30.02 Profit of 420 on sale
2025-05-09	SELL	-14	28.890*	30.03 Profit of 420 on sale
2025-04-30	SELL	-14	26.995*	30.22 Profit of 423 on sale
2025-04-24	SELL	-28	26.780*	30.35 Profit of 850 on sale
2025-04-17	SELL	-14	27.010*	30.54 Profit of 428 on sale
2025-04-15	SELL	-42	27.120*	30.61 Profit of 1,286 on sale
2025-04-14	SELL	-42	26.730*	30.65 Profit of 1,288 on sale
2025-04-09	SELL	-56	26.370*	30.82 Profit of 1,726 on sale
2025-04-07	SELL	-98	27.380*	30.92 Profit of 3,031 on sale
2025-04-04	SELL	-140	28.140*	30.96 Profit of 4,334 on sale
2025-03-31	BUY	14	29.850*	31.00
2025-03-19	SELL	-28	29.850*	31.11 Profit of 871 on sale
2025-03-14	SELL	-84	29.460*	31.17 Profit of 2,619 on sale
2025-03-13	SELL	-28	29.100*	31.20 Profit of 874 on sale
2025-03-12	SELL	-476	29.630*	31.23 Profit of 14,864 on sale
2025-03-07	SELL	-28	28.910*	31.30 Profit of 877 on sale
2025-03-06	SELL	-42	29.800*	31.33 Profit of 1,316 on sale
2025-03-03	SELL	-14	28.440*	31.47 Profit of 441 on sale
2025-02-28	SELL	-84	29.050*	31.51 Profit of 2,647 on sale
2025-02-26	SELL	-14	28.350*	31.62 Profit of 443 on sale
2025-02-25	SELL	-42	28.820*	31.67 Profit of 1,330 on sale
2025-02-18	BUY	70	29.710*	31.87
2025-02-13	BUY	14	30.980*	31.97
2025-02-12	BUY	14	30.530*	32.00
2025-02-11	BUY	42	31.580*	32.01
2025-02-06	BUY	126	30.950*	32.10
2025-01-27	BUY	14	33.910*	32.10
2024-12-30	BUY	70	28.610*	32.30
2024-12-06	BUY	56	29.970*	32.51
2024-12-05	BUY	14	29.870*	32.60
2024-12-04	BUY	70	31.120*	32.65
2024-11-29	BUY	70	30.500*	32.87
2024-11-27	BUY	56	30.710*	33.06
2024-11-26	BUY	14	31.190*	33.15
2024-11-21	BUY	70	30.410*	33.58
2024-11-20	BUY	42	30.000*	33.78
2024-11-18	BUY	168	29.220*	34.32
2024-11-12	BUY	112	31.410*	34.51
2024-11-08	BUY	70	32.160*	34.68
2024-11-07	BUY	210	34.710*	34.68
2024-11-06	BUY	28	34.500*	34.69
2024-10-31	BUY	14	34.140*	35.32

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of COLL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	61,020	0	88,706	68.8%
2025-09-18	41,541	0	67,794	61.3%
2025-09-17	66,618	0	114,347	58.3%
2025-09-16	133,161	0	194,298	68.5%
2025-09-15	152,551	0	212,478	71.8%
2025-09-12	95,136	0	129,598	73.4%
2025-09-11	110,423	0	246,764	44.7%
2025-09-10	53,467	0	99,007	54.0%
2025-09-09	109,513	0	233,493	46.9%
2025-09-08	206,377	2	311,091	66.3%
2025-09-05	78,137	0	150,749	51.8%
2025-09-04	64,006	6,972	105,811	60.5%
2025-09-03	63,593	0	122,600	51.9%
2025-09-02	101,085	0	159,730	63.3%
2025-08-29	46,433	0	126,235	36.8%
2025-08-28	51,923	0	97,387	53.3%
2025-08-27	31,315	0	75,370	41.5%
2025-08-26	40,930	0	153,664	26.6%
2025-08-25	56,670	0	122,837	46.1%
2025-08-22	35,563	0	123,465	28.8%
2025-08-21	36,265	0	85,499	42.4%
2025-08-20	49,364	15	88,020	56.1%
2025-08-19	63,109	50	120,936	52.2%
2025-08-18	29,505	0	92,255	32.0%
2025-08-15	20,662	0	64,211	32.2%
2025-08-14	87,424	0	118,481	73.8%
2025-08-13	49,958	14	132,123	37.8%
2025-08-12	91,824	0	151,451	60.6%
2025-08-11	129,883	3,211	250,035	51.9%
2025-08-08	83,394	0	319,663	26.1%
2025-08-07	193,676	0	339,687	57.0%
2025-08-06	98,233	0	169,420	58.0%
2025-08-05	32,115	0	70,967	45.3%
2025-08-04	36,300	0	70,243	51.7%
2025-08-01	102,275	0	172,380	59.3%
2025-07-31	35,405	0	66,557	53.2%
2025-07-30	21,992	0	61,112	36.0%
2025-07-29	26,689	0	72,676	36.7%
2025-07-28	22,692	0	82,913	27.4%
2025-07-25	30,500	0	69,126	44.1%
2025-07-24	26,485	0	68,767	38.5%
2025-07-23	24,505	0	67,625	36.2%
2025-07-22	41,446	1,004	84,381	49.1%
2025-07-21	32,627	0	70,693	46.2%
2025-07-18	26,588	14	56,895	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE